Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Trial data shows tirzepatide achieves higher average weight loss: 20.9% at 72 weeks on 15mg (SURMOUNT-1) versus 14.9% at 68 weeks on semaglutide 2.4mg (STEP 1)
Common side effects of these medications are gastrointestinal-related issues such as nausea, vomiting, stomachache, diarrhea, and constipation
With a price of just $99 to start, the Noom Microdose GLP-1 Rx Program democratizes access while aiming to make side effects less of a barrier to care
Clinical Evidence Supporting GLP-1 Use in Prediabetes Multiple clinical trials have demonstrated that GLP-1 receptor agonists prevent or delay type 2 diabetes onset in people with prediabetes
If you regain more than 3 to 5 pounds at a lower dose, discuss moving back up with your prescriber
